A marked difference in pathogenesis and immune response induced by differentMycobacterium tuberculosisgenotypes
Tóm tắt
In the last decade, an unprecedented genetic diversity has been disclosed among Mycobacterium tuberculosis strains found worldwide. However, well-conserved genotypes seem to prevail in areas with high incidence of tuberculosis. As this may be related to selective advantages, such as advanced mechanisms to circumvent [M. bovis Bacille Calmette–Guerin (BCG)-induced] host defence mechanisms, we investigated the influence of strain diversity on the course of experimental disease. Twelve M. tuberculosis strains, representing four major genotype families found worldwide today, and the laboratory strain H37Rv were each used to infect BALB/c mice by direct intratracheal injection. Compared with H37Rv, infections with Beijng strains were characterized by extensive pneumonia, early but ephemeral tumour necrosis factor-alpha (TNF-α) and inducible isoform of nitric oxide synthetase (iNOS) expression, and significantly higher earlier mortality. Conversely, Canetti strains induced limited pneumonia, sustained TNF-α and iNOS expression in lungs, and almost 100% survival. Strains of the Somali and the Haarlem genotype families displayed less homogeneous, intermediate rates of survival. Previous BCG vaccination protected less effectively against infection with Beijing strains than against the H37Rv strain. In conclusion, genetically different M. tuberculosis strains evoked markedly different immunopathological events. Bacteria with the Beijing genotype, highly prevalent in Asia and the former USSR, elicited a non-protective immune response in mice and were the most virulent. Future immunological research, particularly on candidate vaccines, should include a broad spectrum of M. tuberculosis genotypes rather than a few laboratory strains.
Từ khóa
Tài liệu tham khảo
Bloom, 1992, Tuberculosis commentary on a reemergent killer, Science, 257, 1055, 10.1126/science.257.5073.1055
Nardell, 1993, Environmental control of tuberculosis, Med Clin North Am, 77, 1315, 10.1016/S0025-7125(16)30196-1
Hernandez-Pando, 1997, Pathogenesis of tuberculosis in mice exposed to low and high doses of an environmental mycobacterial saprophyte, Infect Immun, 65, 3317, 10.1128/iai.65.8.3317-3327.1997
Hill, 1998, The immunogenetics of human infectious diseases, Annu Rev Immunol, 16, 593, 10.1146/annurev.immunol.16.1.593
Bellamy, 1998, Variation in the NRAMP1 gene and susceptibility to tuberculosis in West Africans, N Engl J Med, 338, 640, 10.1056/NEJM199803053381002
Stead, 1992, Genetics and resistance to tuberculosis. Could resistance be enhanced by genetic engineering?, Ann Intern Med, 116, 937, 10.7326/0003-4819-116-11-937
Kramnik, 2000, Genetic control of resistance to experimental infection with virulent Mycobacterium tuberculosis, Proc Nat Acad Sci, 97, 8560, 10.1073/pnas.150227197
Chan, 1992, Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated macrophages, J Exp Med, 175, 1111, 10.1084/jem.175.4.1111
MacMicking, 1997, Nitric oxide and macrophage function, Annu Rev Immunol, 15, 323, 10.1146/annurev.immunol.15.1.323
Seah, 2000, Type 2 cytokine gene activation and its relationship to extent of disease in patients with tuberculosis, J Infect Dis, 181, 385, 10.1086/315200
Wangoo, 2001, Contribution of Th1 and Th2 cells to protection and pathology in experimental models of granulomatous disease, J Immunol, 166, 3432, 10.4049/jimmunol.166.5.3432
Hernandez-Pando, 1996, Correlation between kinetics of Th1/Th2 cells and pathology in a murine model of experimental pulmonary tuberculosis, Immunology, 89, 26
Hernandez-Pando, 1997, Analysis of the local kinetics and localization of interleukin 1α, tumor necrosis factor α and transforming growth factor β during the course of experimental pulmonary tuberculosis, Immunology, 90, 607, 10.1046/j.1365-2567.1997.00193.x
Hernandez-Pando, 2001, Expression of nitric oxide synthase and nitrotyrosine during the evolution of experimental pulmonary tuberculosis, Exp Toxicol Pathol, 53, 257, 10.1078/0940-2993-00182
Valway, 1998, An outbreak involving extensive transmission of a virulent strain of Mycobacterium tuberculosis, N Engl J Med, 338, 633, 10.1056/NEJM199803053381001
Caminero, 2001, Epidemiologic evidence for the spread of a Mycobacterium tuberculosis strain of the ‘Beijing’ genotype on Gran Canaria Island, Am J Respir Crit Care Med, 164, 1165, 10.1164/ajrccm.164.7.2101031
Manca, 1999, Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates, J Immunol, 162, 6740, 10.4049/jimmunol.162.11.6740
Manca, 2001, Virulence of a Mycobacterium tuberculosis isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-α/β, Proc Nac Acad Sci, 98, 5752, 10.1073/pnas.091096998
Bishai, 2001, Tuberculosis transmission − rogue pathogen or rogue patient?, Am J Respir Crit Care Med, 164, 1104, 10.1164/ajrccm.164.7.2108039c
Van Soolingen, 1996, Use of DNA fingerprinting in the epidemiology of tuberculosis
Van Soolingen, 1995, Predominance of a single genotype of Mycobacterium tuberculosis in countries of East Asia, J Clin Microbiol, 33, 3234, 10.1128/jcm.33.12.3234-3238.1995
Kremer, 1999, Comparison of methods based on different molecular epidemiological markers for typing of Mycobacterium tuberculosis complex strains: interlaboratory study of discriminatory power and reproducibility, J Clin Microbiol, 37, 2607, 10.1128/JCM.37.8.2607-2618.1999
Van Embden, 1993, Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standarized methodology, J Clin Microbiol, 31, 406, 10.1128/jcm.31.2.406-409.1993
Qian, 1999, Retrospective analysis of the Beijing family of Mycobacterium tuberculosis in preserved lung tissues, J Clin Microbiol, 37, 471, 10.1128/JCM.37.2.471-474.1999
Van Soolingen, 1995, Comparison of various repetitive DNA elements as genetics markers for strain differentiation and epidemiology of Mycobacterium tuberculosis, J Clin Microbiol, 33, 3234, 10.1128/jcm.33.12.3234-3238.1995
Van Soolingen, 1997, A novel pathogenic taxon of the Mycobacterium tuberculosis complex, Canetti: characterization of an exceptional isolate from Africa, Int J Syst Bacteriol, 47, 1236, 10.1099/00207713-47-4-1236
Huygen, 1992, Spleen cell cytokine secretion in Mycobacterium bovis BCG-infected mice, Infect Immun, 60, 2880, 10.1128/iai.60.7.2880-2886.1992
Hernandez-Pando, 2000, Interactions between hormone-mediated and vaccine mediated immunotherapy for pulmonary tuberculosis in BALB/c mice, Immunology, 100, 391, 10.1046/j.1365-2567.2000.00054.x
Chomzynski, 1993, Reagent for the single step simultaneous isolation of RNA, DNA and proteins from cells and tissue samples, Biotechniques, 15, 532
Tanghe, 1999, Immunogenicity and protective efficacy of tuberculosis DNA vaccines encoding putative phosphate transport receptors, J Immunol, 162, 1113, 10.4049/jimmunol.162.2.1113
Cooper, 1993, Disseminated tuberculosis in interferon gamma gene-disrupted mice, J Exp Med, 178, 2243, 10.1084/jem.178.6.2243
Anh, 2000, Mycobacterium tuberculosis Beijing genotype emerging in Vietnam, Emerg Infect Dis, 6, 302, 10.3201/eid0603.000312
Marttila, 1998, Rapid detection of rifampin-resistant Mycobacterium tuberculosis by sequencing and line probe assay, Scand J Infect Dis, 30, 129, 10.1080/003655498750003492
Portaels, 1999, Addressing multi-drug resistant tuberculosis in penintentiary hospitals and in the general population of the former Soviet Union, Int J Tuberc Lung Dis, 3, 582
Narvskaya, 1999, Genetical marking of Mycobacterium tuberculosis polyresistant strains isolated in the North-West part of Russia, Probl Tuberk, 3, 39
Bifani, 1996, Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family, JAMA, 275, 452, 10.1001/jama.1996.03530300036037
Van Crevel, 2001, Mycobacterium tuberculosis Beijing genotype strains associated with febrile response to treatment, Emerg Infect Dis, 7, 880, 10.3201/eid0705.017518
Daffe, 1991, Novel type specific lipooligosacharides from Mycobacterium tuberculosis, Biochemistry, 30, 378, 10.1021/bi00216a011
Pfyffer, 1998, Mycobacterium canetti, the smooth variant of M. tuberculosis, isolated from a Swiss patient exposed in Africa, Emerg Infect Dis, 4, 631, 10.3201/eid0404.980414
Gerome, 2000, Four new cases of lymph node tuberculosis due to M. tuberculosis subsp. canetti in Djibouti, Horn of Africa
Schaefer, 1970, Pathogenicity of transparent, opaque, and rough variants of Mycobacterium avium in chickens and mice, Am Rev Respir Dis, 102, 499